Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B-Reference-Cited by-同舟云学术

Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B

Published:2018-04-18 Issue:6 Volume:2 Page:747-759
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Huang Shiu‐Feng¹²³,Chang Il‐Chi¹⁴,Hong Chih‐Chen¹⁴,Yen Tseng‐Chang⁵,Chen Chao‐Long⁶,Wu Cheng‐Chung⁷,Tsai Cheng‐Chung⁸,Ho Ming‐Chih⁹,Lee Wei‐Chen¹⁰,Yu Hsien‐Chung¹¹,Shen Ying‐Ying¹²,Eng Hock‐Liew¹³,Wang John¹⁴,Tseng Hui‐Hwa¹⁵,Jeng Yung‐Ming¹⁶,Yeh Chau‐Ting⁴,Chen Chi‐Ling¹⁷,Chen Pei‐Jer¹⁷,Liaw Yun‐Fan⁴^ORCID

Affiliation:

1. Institute of Molecular and Genomic MedicineNational Health Research InstitutesMiaoli Taiwan

2. Department of Anatomic Pathology, Linko Chang Gung Memorial HospitalChang‐Gung UniversityTaoyuan Taiwan

3. Department of Anatomical PathologyChung‐Shan Medical University HospitalTaichung Taiwan

4. Liver Research Unit, Linko Chang Gung Memorial HospitalChang‐Gung UniversityTaoyuan Taiwan

5. Department of Applied Mathematics and Institute of StatisticsNational Chung‐Hsing UniversityTaiChung Taiwan

6. Department of General Surgery, Kaohsiung Chang Gung Memorial HospitalChang‐Gung UniversityKaohsiung Taiwan

7. Department of General SurgeryTaichung Veteran General HospitalTaichung Taiwan

8. Department of General SurgeryKaohsiung Veteran General HospitalKaohsiung Taiwan

9. Department of General SurgeryNational Taiwan University HospitalTaipei Taiwan

10. Department of General Surgery, Linko Chang Gung Memorial HospitalChang‐Gung UniversityTaoyuan Taiwan

11. Department of HepatogastroenterologyKaohsiung Veteran General HospitalKaohsiung Taiwan

12. Core Pathology LaboratoryNational Health Research InstitutesMiaoli Taiwan

13. Department of Pathology, Kaohsiung Chang Gung Memorial HospitalChang‐Gung UniversityKaohsiung Taiwan

14. Department of PathologyTaichung Veteran General HospitalTaichung Taiwan

15. Department of PathologyKaohsiung Veteran General HospitalKaohsiung Taiwan

16. Department of PathologyNational Taiwan University HospitalTaipei Taiwan

17. Graduate Institute of Clinical MedicineNational Taiwan University College of MedicineTaipei Taiwan

Funder

National Science Council

National Research Program for Biopharmaceuticals

Ministry of Science and Technology

National Health Research Institutes

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1182

Reference41 articles.

1. Global cancer statistics, 2012

2. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007

3. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease study 2015;Global Burden of Disease Liver Cancer Collaboration;JAMA,2017

4. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non‐alcoholic fatty liver disease;Than NN;QJM,2017

5. Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of 13 Novel Loci in a Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-11-16

2. Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas;Biomarker Research;2023-07-04

3. Serum HBcrAg and Hepatocellular Carcinoma in a Taiwanese Population Seronegative for HBsAg and Anti-HCV;Clinical Gastroenterology and Hepatology;2023-05

4. Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2023-04

5. Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas;2023-03-10